Program
Friday, September 16th, 2011
04.00 - 07.00 pm Registration
04.00 - 06.00 pm Liver Support-Device Demonstration (English / German)
08.00 pm Welcome Reception
Saturday, September 17th, 2011
07:30 - 10:00 am Registration
8.00 am: Opening
S. Mitzner (Rostock, Germany)
08.10 - 09.30 am: Indications for Liver Support Therapy
Chairman: E. Paganini (Cleveland, USA)
8.10 am J. Stange (Rostock, Germany): Evidence for Efficacy of Liver Support in defined Indications
8.30 am FS. Larsen (Copenhagen, Denmark): Liver Support Techniques in Acute Liver Failure
8.45 am M. Engel (Bad Oyenhausen, Germany): Albumin Dialysis in Circulatory Liver Failure
9.00 am R. Jalan (London, UK): Albumin Dialysis in Cholestatic Liver Disease
9.15 am H. Schmidt (Muenster, Germany): Albumin Dialysis in Chronic Liver Disease
09.30 am Consensus Panel 1: Patient Classifications
Chair: R. Jalan (London, UK)
10.00 am: Coffee Break and Poster Exhibition
10.30 - 11.15 am: How to Perform Liver Support Therapy
Chair: R. Williams (London, UK)
10.30 V. Morabito (Rome, Italy): Dose Adjustment for Liver Support Based on Kinetic Modelling
10.45 R. Stauber (Graz, Austria): Structural and Functional Changes of Albumin in Liver Failure
11.00 S. Koball (Rostock, Germany): Albumin Exchange Therapy and Albumin Dialysis in Liver Failure
11:15 - 11:45 am: Consensus Panel 2: Technical Guidelines
Chair G. Novelli
11.45 am - 1.00 pm: Lunch Break and Meet the Experts
01.00 - 01.30 pm: Poster Session
01.30 - 02.00 pm: Emil Paganini (Cleveland, USA): Extracorporeal Treatment for Organ Assist
The Challenge of Finding the Right Dose
02.00 - 03.15 pm: Technology Review and New Trends
Chair: S. Mitzner (Rostock, Germany)
2.00 S. Klammt (Rostock, Germany): Albumin-Functional Changes in Critical Care Conditions-Is Albumin Binding Function the Parameter for Dosing?
2.15 J. Stange (Rostock, Germany): Impact of Albumin Dialysis on Albumin Binding Function
2.30 F. Oettl (Graz, Austria): Albumin-Structural Changes in Liver Disease
2.45 J. Fernandez (Barcelona, Spain): Albumin Function in Liver Disease
3.00 N. Davies (London, UK): Membrane Improvements in Liver Assist Devices
03.15 - 03.45 Coffee Break and Poster Exhibition
03.45 - 04.15 Ongoing and New Studies
Chair: J. Stange (Rostock, Germany)
3.45 V. Fuhrmann (Vienna, Austria) – Shock Induced Liver Failure
4.00 T. Winters (San Diego, USA) - Liver Support in Acute Alcoholic Hepatitis
4.15 F. Hessel (Berlin, Germany): A Summary of Health Economic Reports on Liver Support
04.30 pm: Consensus Panel 3: Next Steps in Establishing Guidelines for an Efficient Use of Liver Support
Chair: H. Schmidt (Muenster, Germany)
05.30 pm: Concluding Remarks and Best Poster Award
06.15 pm: End of Symposium
08.00 pm: River Boat Tour









